NasdaqGS - Delayed Quote USD

Hologic, Inc. (HOLX)

Compare
71.79 -0.35 (-0.49%)
At close: June 14 at 4:00 PM EDT
71.79 0.00 (0.00%)
After hours: June 14 at 5:31 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
3,960,600.00
4,030,400.00
4,862,800.00
5,632,300.00
3,776,400.00
--
Cost of Revenue
1,983,000.00
1,958,900.00
1,865,400.00
1,836,500.00
1,548,900.00
--
Gross Profit
1,977,600.00
2,071,500.00
2,997,400.00
3,795,800.00
2,227,500.00
--
Operating Expense
1,297,000.00
1,310,000.00
1,366,600.00
1,312,900.00
1,102,500.00
--
Operating Income
680,600.00
761,500.00
1,630,800.00
2,482,900.00
1,125,000.00
--
Net Non Operating Interest Income Expense
6,200.00
9,400.00
-82,200.00
-92,200.00
-112,200.00
--
Other Income Expense
-126,300.00
-94,800.00
39,600.00
-29,600.00
-10,900.00
--
Pretax Income
560,500.00
676,100.00
1,588,200.00
2,361,100.00
1,001,900.00
--
Tax Provision
94,000.00
220,100.00
286,200.00
491,400.00
-108,600.00
--
Net Income Common Stockholders
466,500.00
456,000.00
1,302,000.00
1,871,500.00
1,115,200.00
--
Diluted NI Available to Com Stockholders
466,500.00
456,000.00
1,302,000.00
1,871,500.00
1,115,200.00
--
Basic EPS
1.97
1.85
5.18
7.28
4.24
--
Diluted EPS
1.94
1.83
5.13
7.21
4.21
--
Basic Average Shares
241,639.00
246,772.00
251,527.00
257,046.00
262,727.00
--
Diluted Average Shares
243,506.50
248,831.00
253,845.00
259,706.00
264,613.00
--
Total Operating Income as Reported
542,500.00
668,400.00
1,640,200.00
2,480,300.00
1,105,000.00
--
Total Expenses
3,280,000.00
3,268,900.00
3,232,000.00
3,149,400.00
2,651,400.00
--
Net Income from Continuing & Discontinued Operation
466,500.00
456,000.00
1,302,000.00
1,871,500.00
1,115,200.00
--
Normalized Income
581,439.61
518,749.40
1,294,866.00
1,890,666.40
1,129,800.00
--
Interest Income
120,300.00
120,500.00
12,900.00
1,400.00
4,300.00
--
Interest Expense
114,100.00
111,100.00
95,100.00
93,600.00
116,500.00
--
Net Interest Income
6,200.00
9,400.00
-82,200.00
-92,200.00
-112,200.00
--
EBIT
674,600.00
787,200.00
1,683,300.00
2,454,700.00
1,118,400.00
--
EBITDA
993,400.00
1,110,600.00
2,113,400.00
2,861,600.00
1,494,400.00
--
Reconciled Cost of Revenue
1,696,600.00
1,663,600.00
1,480,500.00
1,471,800.00
1,212,600.00
--
Reconciled Depreciation
318,800.00
323,400.00
430,100.00
406,900.00
376,000.00
--
Net Income from Continuing Operation Net Minority Interest
466,500.00
456,000.00
1,302,000.00
1,871,500.00
1,115,200.00
--
Total Unusual Items Excluding Goodwill
-138,100.00
-93,100.00
8,700.00
-24,200.00
-20,000.00
--
Total Unusual Items
-138,100.00
-93,100.00
8,700.00
-24,200.00
-20,000.00
--
Normalized EBITDA
1,131,500.00
1,203,700.00
2,104,700.00
2,885,800.00
1,514,400.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-23,160.39
-30,350.60
1,566.00
-5,033.60
-5,400.00
--
9/30/2019 - 3/1/1990

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
93.47
-0.77%
 
XRAY DENTSPLY SIRONA Inc.
26.11
-2.21%
 
ALC Alcon Inc.
90.68
-0.73%
 
BAX Baxter International Inc.
33.78
+0.12%
 
WST West Pharmaceutical Services, Inc.
333.25
-0.90%
 
RMD ResMed Inc.
211.73
-0.31%
 
TFX Teleflex Incorporated
208.29
-0.48%
 
ATRI Atrion Corporation
451.10
-0.15%
 
RGEN Repligen Corporation
125.62
-0.25%
 
BDX Becton, Dickinson and Company
233.73
+0.76%